Rhythm Pharmaceuticals Inc (RYTM)
39.55
-0.83
(-2.06%)
USD |
NASDAQ |
May 15, 15:19
Rhythm Pharmaceuticals Cash from Operations (Quarterly): -40.74M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -40.74M |
| December 31, 2023 | -29.38M |
| September 30, 2023 | -29.25M |
| June 30, 2023 | -41.09M |
| March 31, 2023 | -36.43M |
| December 31, 2022 | -34.00M |
| September 30, 2022 | -46.99M |
| June 30, 2022 | -38.81M |
| March 31, 2022 | -53.63M |
| December 31, 2021 | -40.47M |
| September 30, 2021 | -40.16M |
| June 30, 2021 | -31.84M |
| March 31, 2021 | -33.53M |
| December 31, 2020 | -29.12M |
| September 30, 2020 | -27.03M |
| Date | Value |
|---|---|
| June 30, 2020 | -29.73M |
| March 31, 2020 | -36.10M |
| December 31, 2019 | -32.22M |
| September 30, 2019 | -33.60M |
| June 30, 2019 | -25.55M |
| March 31, 2019 | -31.38M |
| December 31, 2018 | -20.98M |
| September 30, 2018 | -16.94M |
| June 30, 2018 | -12.48M |
| March 31, 2018 | -11.65M |
| December 31, 2017 | -7.885M |
| September 30, 2017 | -8.417M |
| June 30, 2017 | -6.142M |
| March 31, 2017 | -7.016M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-53.63M
Minimum
Mar 2022
-25.55M
Maximum
Jun 2019
-35.48M
Average
-33.80M
Median
Cash from Operations (Quarterly) Benchmarks
| Pfizer Inc | 1.09B |
| Amicus Therapeutics Inc | -29.70M |
| Insmed Inc | -184.04M |
| Altimmune Inc | -16.53M |
| Regeneron Pharmaceuticals Inc | 1.512B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 30.05M |
| Cash from Financing (Quarterly) | 4.243M |
| Free Cash Flow | -140.47M |
| Free Cash Flow Per Share (Quarterly) | -0.6774 |
| Free Cash Flow to Equity (Quarterly) | -40.74M |
| Free Cash Flow to Firm (Quarterly) | -39.03M |
| Free Cash Flow Yield | -6.07% |